Tag Archives: cannabinoids

New Practice Resource: Medical Cannabis Evidence Guide

New Practice Resource: Medical Cannabis Evidence Guide

New Practice Resource: Medical Cannabis Evidence Guide

OTTAWA, Feb. 15, 2018 /Weed Wire/ — As part of its ongoing efforts to provide Canadian pharmacists with practice tools and resources, CPhA has developed a new medical cannabis evidence guide.

International Cannabinoid Research Society Heading to Jerusalem in 2021

International Cannabinoid Research Society Heading to Jerusalem in 2021

Cannabis scientists may want to start planning for a trip to the Holy Land. The International Cannabinoid Research Society, the longest running scientific society focused on cannabis research, has picked Jerusalem for the site of its annual International Symposium on the Cannabinoids in 2021.

Axim Biotech - MedChew Rx

AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment

NEW YORK, June 23, 2017 /Weed Wire/ — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469, a patent of invention that involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment.

Wisconsin Files Lawsuits Over Milwaukee Synthetic THC

Wisconsin Files Lawsuits Over Synthetic THC in Milwaukee

On May 23, 2017, two retail shops were sued by Wisconsin’s departments of justice and consumer protection. The Milwaukee stores broke the law as they falsely advertised synthetic THC as household products.

Enter England: Oxford University Launches Medical Cannabis Research Program

Enter England: Oxford University Launches Medical Cannabis Research Program

Oxford University, one of the oldest and most prestigious universities in the world, recently announced that it is launching a program to research the therapeutic benefits of cannabinoids in the treatment of cancer, inflammatory disease and pain.

Medical Marijuana Inc Fails To Delight Investors

Medical Marijuana Inc Fails to Delight Investors

In the last trading session, the stock price of Medical Marijuana Inc (OTCMKTS:MJNA) declined more than 8% to close the day at $0.112. The decline came at a share volume of 24.74 million compared to average share volume of 17.32 million.

'Cannabis in Parkinson's Disease: Growing Like a Weed!'

‘Cannabis in Parkinson’s Disease: Growing Like a Weed!’

“Cannabis in Parkinson’s Disease: Growing Like a Weed!” was presented at the University of Colorado School of Medicine’s Neurology Grand Rounds on Jan. 18, 2017.

DEA Issues New Rule to Ban Cannabidiol

DEA Issues New Rule to Ban Cannabidiol

On Dec. 14, 2016, the United States Drug Enforcement Administration announced a new rule that makes hemp-based cannabidiol a federally illegal substance. Under the new rules, liquid extracts derived from plants of the cannabis genus that contain one or more cannabinoids are now considered a schedule I substance.

Post-Traumatic Stress and National TV Spot

DEA Hurts Growing Industry and Exceeds its Authority Regarding Scheduling Controlled Substances​;​ Enacts Final Rule Seeking to Make Any Extract of the Cannabis Plant a Schedule 1 Drug

DENVER, Dec. 15, 2016 /Weed Wire/ — On December 13, 2016, the DEA issued its Final Rule, “Establishment of New Drug Code for Marihuana Extract,” which serves to potentially devastate developing businesses and consumer, textile and manufacturing industries related to cannabinoids.

Dive into the Science and Medicine of Cannabis

Dive into the Science and Medicine of Cannabis

Cannabinoids – what are they? How do they affect the human body? Are they really medicinal? On Nov. 16, 2016, Marijuana Investor Summit is bringing the Science and Medicine of Cannabis to the Palms Casino Resort in Las Vegas, Nevada, to answer these questions and more.

Alaska Welcomes First Marijuana Testing Lab

Alaska Welcomes First Marijuana Testing Lab

On Oct. 24, 2016, Alaska’s first marijuana testing lab opened for business. CannTest LLC, in Ship Creek, opened its doors at 10:30 a.m. and was immediately met with 15 samples to test from two marijuana cultivators — Greatland Ganja and Green Rush Gardens LLC.


Skinvisible Signs Global Licensing Agreement for Its Cannabis Products

LAS VEGAS, Sept. 15, 2016 /Weed Wire/ — Skinvisible Pharmaceuticals, Inc., (OTCQB: SKVI), developers of patented Invisicare® polymer delivery systems, announces it has licensed the exclusive world rights to its topical and transdermal cannabis products formulated with Invisicare to CannaSkin, LLC, a cannabis product licensing company with international contacts in the medical marijuana industry.

Eugene Monroe

Former NFL Player Begins Column For The Cannabist

Medical marijuana advocate and former Baltimore Ravens player Eugene Monroe published his first column for The Cannabist on Aug. 1, 2016. “On a mission to get the NFL to accept cannabinoids as a viable option for pain,” says part of Monroe’s biographical information at the end of the column. The Baltimore Ravens released Monroe in June 2016.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Develops Inhalation Medication for Those Suffering Asthma/COPD via Nebulizer, Targets National Markets

IRVINE, Calif., July 29, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce they will release an inhalation medication for those suffering asthma/COPD for use in patient nebulizers.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Guidance; Corporate Headquarters Relocated to California as it Negotiates for a Los Angeles, California Laboratory/Medical Treatment Center

LOS ANGELES, June 30, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced the relocation of their corporate headquarters to Irvine, California.


Enter Cannabis 2.0: LucidMood Launches Online Marketplace

On April 20, 2016, Chooze Corp. launched its first product, LucidMood, a line of vaporizable pucks infused with terpenes, distinctive aromatic compounds, that induce immediate shifts in the individual moods of those who have THC in their systems.

LucidMood by Chooze Corp.

Chooze Corp.

Chooze Corp. develops Mood-enhancing Cannabis products — brands that deliver the mood-enhancing effects of cannabis in the safest, healthiest, most environmentally conscious way possible. Our first product, LucidMood, is a line of terpene-infused vaporizable pucks that produce an immediate shift in the mood of anyone who has THC in their system.


Paralympic Athlete Suspended After Testing Positive for Cannabinoids

On Tuesday, Nov. 17, 2015, the International Paralympic Committee announced that it has suspended Alexander Zverev, a Russian Paralympic sprinter, for violating a rule of the World Anti-Doping Agency.


DigiPath Labs Successfully Completes Proficiency Testing for Cannabis Potency

LAS VEGAS, Oct. 9, 2015 /PRNewswire/ — DigiPath Labs, a subsidiary of DigiPath, Inc.(OTCBB and OTCQB: DIGP), recently successfully completed voluntary proficiency testing of its ability to detect cannabinoids and terpenoids, accurately identifying potency levels of five cannabinoids and 10 terpenoids in unknown samples.


Evoxe Labs Announces Medicinal Cannabis Product Launch

LOS ANGELES, Aug. 24, 2015 /PRNewswire/ — Evoxe Laboratories, the new and pioneering developer of medicinal cannabis consumption technologies, today announces their debut product offerings in California, as well as partnerships with Sacramento’s TBD Music Festival and Irvine’s Safe In Sound Festival this September.

Zynerba IPO

Zynerba IPO a Big $275 Million Entry for Cannabinoids

It has been a bit of a dry spell for decent IPOs in the cannabis space. But the rains have come down with the initial public offering of Devon, Pennsylvania-based Zynerba Pharmaceuticals (NASDAQ: ZYNE).


Study: Medical Marijuana May Help Heal Broken Bones

When people say “medical marijuana,” they often think of cancer patients, people suffering from PTSD, or persons struggling with chronic pain. There is a huge laundry list of ailments that medical marijuana can purportedly treat, and the newest addition to that list is broken bones.

MyDx CannaDx

MyDx Looks to Crack Open the Green Leaf

MyDx’s hardware/software ecosystem has a very easy value proposition to dish out: simple, instant testing of solids, liquids and gases to measure their positive attributes, and whether there’s any pesticides or other no-gooders in your food, water and air.

Viridian Capital Advisors Report TheStreet Index and Northsight Capital and MSN and Conde Nast and Virtual Conference

CannaPharmaRx to Exhibit at the Cannabis World Congress & Business Expo in NYC

NEW YORK, N.Y., June 17, 2015 /PR Newswire/ — CannaPharmaRx (OTCQB:CPMD), a leader in the research, development, and commercialization of cannabinoid-based drug products, is pleased to announce that it will be exhibiting at the 2nd Annual Cannabis World Congress & Business Expo. The conference will be held at the Jacob Javits Center in New York, NY from Wednesday, June 17 through Friday, June 19. CannaPharmaRx will exhibit in booth # 316.